Unopposed EZH2 activity is also a driver of cancers determined by the loss of the core subunit SNF5/SMARCB1 in the SWI/SNF complex as demonstrated in rhabdoid tumor, a highly malignant aggressive type of pediatric cancer (17, 18). Here, SMARCB1 is linked to rhabdoid tumor.